Vaccinex (VCNX) Competitors $0.98 +0.01 (+0.92%) As of 07/15/2025 11:11 AM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock VCNX vs. BMRA, TCRT, TRAW, OBSV, GOVX, CLDI, PMCB, LIXT, ORGS, and GNPXShould you be buying Vaccinex stock or one of its competitors? The main competitors of Vaccinex include Biomerica (BMRA), Alaunos Therapeutics (TCRT), Traws Pharma (TRAW), ObsEva (OBSV), GeoVax Labs (GOVX), Calidi Biotherapeutics (CLDI), Nuvilex (PMCB), Lixte Biotechnology (LIXT), Orgenesis (ORGS), and GENPREX (GNPX). These companies are all part of the "pharmaceutical products" industry. Vaccinex vs. Its Competitors Biomerica Alaunos Therapeutics Traws Pharma ObsEva GeoVax Labs Calidi Biotherapeutics Nuvilex Lixte Biotechnology Orgenesis GENPREX Vaccinex (NASDAQ:VCNX) and Biomerica (NASDAQ:BMRA) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their profitability, media sentiment, valuation, earnings, analyst recommendations, dividends, institutional ownership and risk. Is VCNX or BMRA more profitable? Vaccinex has a net margin of 0.00% compared to Biomerica's net margin of -85.42%. Vaccinex's return on equity of 0.00% beat Biomerica's return on equity.Company Net Margins Return on Equity Return on Assets VaccinexN/A N/A -383.58% Biomerica -85.42%-85.90%-61.06% Which has higher valuation and earnings, VCNX or BMRA? Biomerica has higher revenue and earnings than Vaccinex. Biomerica is trading at a lower price-to-earnings ratio than Vaccinex, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioVaccinex$388K6.56-$20.25M-$48.27-0.02Biomerica$5.41M1.44-$5.98M-$2.32-1.32 Do institutionals & insiders believe in VCNX or BMRA? 50.1% of Vaccinex shares are held by institutional investors. Comparatively, 22.3% of Biomerica shares are held by institutional investors. 51.5% of Vaccinex shares are held by insiders. Comparatively, 15.0% of Biomerica shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth. Does the media refer more to VCNX or BMRA? In the previous week, Biomerica had 1 more articles in the media than Vaccinex. MarketBeat recorded 1 mentions for Biomerica and 0 mentions for Vaccinex. Biomerica's average media sentiment score of 1.87 beat Vaccinex's score of 0.00 indicating that Biomerica is being referred to more favorably in the news media. Company Overall Sentiment Vaccinex Neutral Biomerica Very Positive Which has more volatility and risk, VCNX or BMRA? Vaccinex has a beta of 1.1, indicating that its share price is 10% more volatile than the S&P 500. Comparatively, Biomerica has a beta of 0.35, indicating that its share price is 65% less volatile than the S&P 500. SummaryVaccinex beats Biomerica on 7 of the 13 factors compared between the two stocks. Get Vaccinex News Delivered to You Automatically Sign up to receive the latest news and ratings for VCNX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding VCNX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart VCNX vs. The Competition Export to ExcelMetricVaccinexPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$2.55M$761.73M$5.56B$9.28BDividend YieldN/A4.84%4.23%4.03%P/E Ratio-0.021.4128.6419.62Price / Sales6.5625.52430.8295.68Price / CashN/A19.5636.0257.93Price / Book-0.386.918.155.59Net Income-$20.25M-$4.17M$3.24B$257.73M7 Day Performance9.99%1.54%-0.64%-0.23%1 Month Performance37.87%1.43%4.92%7.98%1 Year Performance-83.60%7.61%25.99%13.16% Vaccinex Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)VCNXVaccinex0.8186 of 5 stars$0.98+0.9%N/A-84.3%$2.55M$388K-0.0240BMRABiomerica1.4977 of 5 stars$3.40+4.0%N/A+4.3%$8.32M$5.41M-1.4760TCRTAlaunos Therapeutics0.5992 of 5 stars$5.11+2.2%N/A-50.1%$8.20M$11K-2.0140Gap DownTRAWTraws Pharma0.6125 of 5 stars$1.45flatN/AN/A$8.07M$230K-0.0417OBSVObsEvaN/AN/AN/AN/A$7.94MN/A-0.1150Gap DownGOVXGeoVax Labs2.215 of 5 stars$0.50+4.6%$11.10+2,110.3%-75.4%$7.65M$3.95M-0.1410Analyst UpgradeCLDICalidi Biotherapeutics0.5623 of 5 stars$0.24-2.3%N/A-67.1%$7.64MN/A0.0038PMCBNuvilex2.9923 of 5 stars$1.10-0.9%N/A-46.6%$7.62MN/A1.494Gap UpLIXTLixte Biotechnology0.244 of 5 stars$2.24-20.8%N/A+53.9%$7.60MN/A-1.544Gap DownHigh Trading VolumeORGSOrgenesis1.7422 of 5 stars$1.51+13.5%N/AN/A$7.25M$662K0.00150GNPXGENPREX1.3323 of 5 stars$0.26-1.2%N/A-85.2%$7.24MN/A0.0020Positive NewsGap Up Related Companies and Tools Related Companies BMRA Competitors TCRT Competitors TRAW Competitors OBSV Competitors GOVX Competitors CLDI Competitors PMCB Competitors LIXT Competitors ORGS Competitors GNPX Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:VCNX) was last updated on 7/16/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredAll New Social Security Numbers coming July 23?To All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredCentral Banks Are Hoarding Gold – Should You?The AI boom isn’t just transforming technology—it’s redefining global power, increasing government debt, and u...Lear Capital | SponsoredWhich Gold Miner Trades at 30% of NAV? The One Buffett WantsSome of the world’s best gold developers are trading at just 30% of NAV — like buying a dollar for 30 cents. ...Golden Portfolio | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredThe Next Commodity Crisis Just Got a Name: SilverElon's Next Market Move Could Send Silver Soaring Every industry Elon Musk touches explodes—from Tesla to S...Priority Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vaccinex, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Vaccinex With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free VCNX Stock Alerts